Heijman J - Search Results

1

Is ageing a modifiable risk factor for atrial fibrillation?

Heijman J, Madreiter-Sokolowski CT. Heijman J, et al. Cardiovasc Res. 2024 Apr 30;120(5):440-442. doi: 10.1093/cvr/cvae040. Cardiovasc Res. 2024. PMID: 38408875 No abstract available.

2

Adiposity-associated atrial fibrillation: molecular determinants, mechanisms, and clinical significance.

Gawałko M, Saljic A, Li N, Abu-Taha I, Jespersen T, Linz D, Nattel S, Heijman J, Fender A, Dobrev D. Gawałko M, et al. Among authors: heijman j. Cardiovasc Res. 2023 May 2;119(3):614-630. doi: 10.1093/cvr/cvac093. Cardiovasc Res. 2023. PMID: 35689487 Free PMC article. Review.

3

Why translation from basic discoveries to clinical applications is so difficult for atrial fibrillation and possible approaches to improving it.

Nattel S, Sager PT, Hüser J, Heijman J, Dobrev D. Nattel S, et al. Among authors: heijman j. Cardiovasc Res. 2021 Jun 16;117(7):1616-1631. doi: 10.1093/cvr/cvab093. Cardiovasc Res. 2021. PMID: 33769493 Free PMC article. Review.

4

The value of basic research insights into atrial fibrillation mechanisms as a guide to therapeutic innovation: a critical analysis.

Heijman J, Algalarrondo V, Voigt N, Melka J, Wehrens XH, Dobrev D, Nattel S. Heijman J, et al. Cardiovasc Res. 2016 Apr 1;109(4):467-79. doi: 10.1093/cvr/cvv275. Epub 2015 Dec 23. Cardiovasc Res. 2016. PMID: 26705366 Free PMC article. Review.

5

Computational models of atrial fibrillation: achievements, challenges, and perspectives for improving clinical care.

Heijman J, Sutanto H, Crijns HJGM, Nattel S, Trayanova NA. Heijman J, et al. Cardiovasc Res. 2021 Jun 16;117(7):1682-1699. doi: 10.1093/cvr/cvab138. Cardiovasc Res. 2021. PMID: 33890620 Free PMC article. Review.

6

Treatment of atrial fibrillation with doxapram: TASK-1 potassium channel inhibition as a novel pharmacological strategy.

Wiedmann F, Beyersdorf C, Zhou XB, Kraft M, Paasche A, Jávorszky N, Rinné S, Sutanto H, Büscher A, Foerster KI, Blank A, El-Battrawy I, Li X, Lang S, Tochtermann U, Kremer J, Arif R, Karck M, Decher N, van Loon G, Akin I, Borggrefe M, Kallenberger S, Heijman J, Haefeli WE, Katus HA, Schmidt C. Wiedmann F, et al. Among authors: heijman j. Cardiovasc Res. 2022 Jun 22;118(7):1728-1741. doi: 10.1093/cvr/cvab177. Cardiovasc Res. 2022. PMID: 34028533

7

Long-QT mutation p.K557E-Kv7.1: dominant-negative suppression of IKs, but preserved cAMP-dependent up-regulation.

Spätjens RL, Bébarová M, Seyen SR, Lentink V, Jongbloed RJ, Arens YH, Heijman J, Volders PG. Spätjens RL, et al. Among authors: heijman j. Cardiovasc Res. 2014 Oct 1;104(1):216-25. doi: 10.1093/cvr/cvu191. Epub 2014 Aug 18. Cardiovasc Res. 2014. PMID: 25139741

8

The Atrium in Atrial Fibrillation - A Clinical Review on How to Manage Atrial Fibrotic Substrates.

Cunha PS, Laranjo S, Heijman J, Oliveira MM. Cunha PS, et al. Among authors: heijman j. Front Cardiovasc Med. 2022 Jul 4;9:879984. doi: 10.3389/fcvm.2022.879984. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 35859594 Free PMC article. Review.

9

Translational Challenges in Atrial Fibrillation.

Heijman J, Guichard JB, Dobrev D, Nattel S. Heijman J, et al. Circ Res. 2018 Mar 2;122(5):752-773. doi: 10.1161/CIRCRESAHA.117.311081. Circ Res. 2018. PMID: 29496798 Review.

10

Commentary: EP-PINNs: Cardiac electrophysiology characterisation using physics-informed neural networks.

Meier S, Heijman J. Meier S, et al. Among authors: heijman j. Front Cardiovasc Med. 2022 Aug 24;9:1003652. doi: 10.3389/fcvm.2022.1003652. eCollection 2022. Front Cardiovasc Med. 2022. PMID: 36093140 Free PMC article. No abstract available.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

143 results

Search Page